WILLIAM M MOORE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM M MOORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM M MOORE. WILLIAM M MOORE is Director in CRITICARE SYSTEMS INC /DE/ ($CXIM) and Director in UROLOGIX INC ($ULGX) and Chairman and CEO in IRIDEX CORP ($IREX) and Director in NATUS MEDICAL INC ($BABY).
Latest Insider Trading Transactions of WILLIAM M MOORE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CXIM, IRIX, BABY, ULGX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2019 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.65 | 91 | 423 | 201,990 | 202.1 K to 202 K (-0.05 %) |
| Mar 25 2019 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.38 | 88 | 385 | 202,081 | 202.2 K to 202.1 K (-0.04 %) |
| Feb 25 2019 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.77 | 108 | 515 | 202,169 | 202.3 K to 202.2 K (-0.05 %) |
| Jan 25 2019 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.60 | 107 | 492 | 202,277 | 202.4 K to 202.3 K (-0.05 %) |
| Jan 07 2019 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.48 | 4,325 | 19,376 | 202,384 | 206.7 K to 202.4 K (-2.09 %) |
| Dec 26 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.07 | 91 | 370 | 206,709 | 206.8 K to 206.7 K (-0.04 %) |
| Dec 26 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 4.07 | 91 | 370 | 206,709 | 206.8 K to 206.7 K (-0.04 %) |
| Dec 13 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 4.34 | 10,000 | 43,443 | 206,800 | 196.8 K to 206.8 K (+5.08 %) |
| Dec 13 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 0.00 | 1,462 | 0 | 196,800 | 198.3 K to 196.8 K (-0.74 %) |
| Dec 13 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 4.34 | 10,000 | 43,443 | 206,800 | 196.8 K to 206.8 K (+5.08 %) |
| Dec 13 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 0.00 | 1,462 | 0 | 196,800 | 198.3 K to 196.8 K (-0.74 %) |
| Nov 27 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 4.71 | 10,000 | 47,144 | 211,800 | 201.8 K to 211.8 K (+4.96 %) |
| Sep 17 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 6.56 | 10,000 | 65,600 | 201,800 | 191.8 K to 201.8 K (+5.21 %) |
| Jul 31 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Grant | A | 0.00 | 40,000 | 0 | 191,800 | 151.8 K to 191.8 K (+26.35 %) |
| Jun 06 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 3.95 | 5,000 | 19,750 | 0 | |
| Jun 06 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 3.75 | 5,000 | 18,750 | 0 | |
| Jun 06 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | M | 3.95 | 5,000 | 19,750 | 151,800 | 146.8 K to 151.8 K (+3.41 %) |
| Jun 06 2018 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | M | 3.75 | 5,000 | 18,750 | 146,800 | 141.8 K to 146.8 K (+3.53 %) |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Option Exercise | M | 24.50 | 3,000 | 73,500 | 0 | |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Option Exercise | M | 10.69 | 5,000 | 53,450 | 0 | |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 35.91 | 3,000 | 107,730 | 89,402 | 92.4 K to 89.4 K (-3.25 %) |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Buy | M | 24.50 | 3,000 | 73,500 | 92,402 | 89.4 K to 92.4 K (+3.36 %) |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 35.91 | 5,000 | 179,550 | 89,402 | 94.4 K to 89.4 K (-5.30 %) |
| May 18 2018 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Buy | M | 10.69 | 5,000 | 53,450 | 94,402 | 89.4 K to 94.4 K (+5.59 %) |
| Dec 15 2017 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 7.84 | 5,000 | 39,200 | 83,944 | 78.9 K to 83.9 K (+6.33 %) |
| Nov 15 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 41.01 | 5,000 | 205,050 | 89,402 | 94.4 K to 89.4 K (-5.30 %) |
| Sep 18 2017 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 9.42 | 1,800 | 16,956 | 372,434 | 370.6 K to 372.4 K (+0.49 %) |
| Aug 29 2017 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | J | 0.00 | 4,703 | 0 | 370,634 | 365.9 K to 370.6 K (+1.29 %) |
| Aug 15 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 34.10 | 3,000 | 102,300 | 94,402 | 97.4 K to 94.4 K (-3.08 %) |
| Jul 27 2017 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 9.54 | 157,000 | 1,497,780 | 157,000 | |
| Jul 27 2017 | IRIX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Grant | A | 9.54 | 15,000 | 143,100 | 365,931 | 350.9 K to 365.9 K (+4.27 %) |
| Jun 23 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Grant | A | 35.60 | 4,100 | 145,960 | 30,410 | 26.3 K to 30.4 K (+15.58 %) |
| Mar 14 2017 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 3.90 | 5,000 | 19,500 | 0 | |
| Mar 14 2017 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | M | 0.00 | 5,000 | 0 | 350,931 | 345.9 K to 350.9 K (+1.45 %) |
| Mar 14 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Option Exercise | M | 16.38 | 5,000 | 81,900 | 5,000 | |
| Mar 14 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Buy | M | 16.38 | 5,000 | 81,900 | 97,402 | 92.4 K to 97.4 K (+5.41 %) |
| Mar 06 2017 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 37.26 | 5,000 | 186,300 | 92,402 | 97.4 K to 92.4 K (-5.13 %) |
| Jun 03 2016 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Grant | A | 33.46 | 4,400 | 147,224 | 26,310 | 21.9 K to 26.3 K (+20.08 %) |
| Apr 28 2016 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Option Exercise | M | 16.78 | 5,000 | 83,900 | 5,000 | |
| Apr 28 2016 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Buy | M | 16.78 | 5,000 | 83,900 | 97,402 | 92.4 K to 97.4 K (+5.41 %) |
| Mar 17 2016 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 2.27 | 5,000 | 11,350 | 0 | |
| Mar 17 2016 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | M | 2.27 | 5,000 | 11,350 | 345,931 | 340.9 K to 345.9 K (+1.47 %) |
| Mar 03 2016 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Grant | A | 0.00 | 50,000 | 0 | 340,931 | 290.9 K to 340.9 K (+17.19 %) |
| Nov 19 2015 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | P | 9.83 | 10,000 | 98,326 | 290,931 | 280.9 K to 290.9 K (+3.56 %) |
| Sep 16 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 40.76 | 5,994 | 244,315 | 92,402 | 98.4 K to 92.4 K (-6.09 %) |
| Sep 16 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 40.27 | 4,000 | 161,080 | 98,396 | 102.4 K to 98.4 K (-3.91 %) |
| Sep 10 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 40.09 | 3,006 | 120,511 | 102,396 | 105.4 K to 102.4 K (-2.85 %) |
| Aug 20 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 45.62 | 3,000 | 136,860 | 105,402 | 108.4 K to 105.4 K (-2.77 %) |
| Aug 14 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 45.55 | 3,006 | 136,923 | 108,402 | 111.4 K to 108.4 K (-2.70 %) |
| Aug 14 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 45.54 | 994 | 45,267 | 111,408 | 112.4 K to 111.4 K (-0.88 %) |
| Jun 15 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Option Exercise | A | 14.34 | 5,000 | 71,700 | 10,000 | |
| Jun 15 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 41.30 | 6,000 | 247,800 | 112,402 | 118.4 K to 112.4 K (-5.07 %) |
| Jun 15 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Grant | A | 14.34 | 5,000 | 71,700 | 21,910 | 16.9 K to 21.9 K (+29.57 %) |
| Jun 12 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Grant | A | 40.61 | 3,250 | 131,983 | 21,910 | 18.7 K to 21.9 K (+17.42 %) |
| Jun 01 2015 | BABY | NATUS MEDICAL INC | MOORE WILLIAM M | Director | Sell | S | 38.29 | 6,000 | 229,740 | 118,402 | 124.4 K to 118.4 K (-4.82 %) |
| Mar 16 2015 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Option Exercise | M | 0.00 | 190,000 | 0 | 0 | |
| Mar 16 2015 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Payment of Exercise | F | 9.08 | 61,465 | 558,102 | 280,931 | 342.4 K to 280.9 K (-17.95 %) |
| Mar 16 2015 | IREX | IRIDEX CORP | MOORE WILLIAM M | Chairman and CEO | Buy | M | 0.00 | 190,000 | 0 | 342,396 | 152.4 K to 342.4 K (+124.68 %) |
| Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.00 | 5,000 | 5,000 | 10,000 | 5 K to 10 K (+100.00 %) |
| Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.00 | 5,000 | 5,000 | 9,000 | 4 K to 9 K (+125.00 %) |
| Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 5,000 | 4,750 | 5,000 | 0 to 5 K |
| Nov 18 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 5,000 | 4,750 | 59,154 | 54.2 K to 59.2 K (+9.23 %) |
| Nov 12 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Option Exercise | A | 1.06 | 10,000 | 10,600 | 10,000 | |
| Nov 12 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Grant | A | 0.00 | 8,774 | 0 | 54,154 | 45.4 K to 54.2 K (+19.33 %) |
| May 13 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 1,500 | 1,275 | 45,380 | 43.9 K to 45.4 K (+3.42 %) |
| May 05 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 100 | 85 | 43,880 | 43.8 K to 43.9 K (+0.23 %) |
| May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.82 | 563 | 462 | 43,780 | 43.2 K to 43.8 K (+1.30 %) |
| May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.82 | 200 | 164 | 43,217 | 43 K to 43.2 K (+0.46 %) |
| May 04 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.78 | 737 | 575 | 43,017 | 42.3 K to 43 K (+1.74 %) |
| May 01 2009 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.85 | 1,500 | 1,275 | 42,280 | 40.8 K to 42.3 K (+3.68 %) |
| Nov 13 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
| May 23 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.11 | 500 | 555 | 40,780 | 40.3 K to 40.8 K (+1.24 %) |
| May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.96 | 4,000 | 3,840 | 39,800 | 35.8 K to 39.8 K (+11.17 %) |
| May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 1,000 | 950 | 35,800 | 34.8 K to 35.8 K (+2.87 %) |
| May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.94 | 1,000 | 940 | 34,800 | 33.8 K to 34.8 K (+2.96 %) |
| May 14 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 1,000 | 930 | 33,800 | 32.8 K to 33.8 K (+3.05 %) |
| May 16 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.98 | 480 | 470 | 40,280 | 39.8 K to 40.3 K (+1.21 %) |
| May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 800 | 744 | 32,800 | 32 K to 32.8 K (+2.50 %) |
| May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.92 | 4,000 | 3,680 | 32,000 | 28 K to 32 K (+14.29 %) |
| May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.91 | 1,000 | 910 | 28,000 | 27 K to 28 K (+3.70 %) |
| May 12 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.91 | 1,000 | 910 | 27,000 | 26 K to 27 K (+3.85 %) |
| May 08 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.93 | 1,000 | 930 | 26,000 | 25 K to 26 K (+4.00 %) |
| Mar 07 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.98 | 2,000 | 1,960 | 25,000 | 23 K to 25 K (+8.70 %) |
| Mar 07 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.97 | 5,000 | 4,850 | 23,000 | 18 K to 23 K (+27.78 %) |
| Mar 06 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 2,000 | 1,900 | 18,000 | 16 K to 18 K (+12.50 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.04 | 2,000 | 2,080 | 16,000 | 14 K to 16 K (+14.29 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.03 | 2,000 | 2,060 | 14,000 | 12 K to 14 K (+16.67 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.02 | 800 | 816 | 12,000 | 11.2 K to 12 K (+7.14 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.95 | 2,000 | 1,900 | 11,200 | 9.2 K to 11.2 K (+21.74 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 0.94 | 200 | 188 | 9,200 | 9 K to 9.2 K (+2.22 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.08 | 3,000 | 3,240 | 9,000 | 6 K to 9 K (+50.00 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.07 | 1,000 | 1,070 | 6,000 | 5 K to 6 K (+20.00 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.06 | 1,000 | 1,060 | 5,000 | 4 K to 5 K (+25.00 %) |
| Mar 04 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.05 | 2,000 | 2,100 | 4,000 | 2 K to 4 K (+100.00 %) |
| Mar 03 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.05 | 2,000 | 2,100 | 2,000 | 0 to 2 K |
| Mar 03 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.04 | 1,000 | 1,040 | 1,000 | 0 to 1,000 |
| Mar 03 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.04 | 2,000 | 2,080 | 4,000 | 2 K to 4 K (+100.00 %) |
| Mar 03 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Buy | P | 1.03 | 2,000 | 2,060 | 2,000 | 0 to 2 K |
| Feb 26 2008 | ULGX | UROLOGIX INC | MOORE WILLIAM M | Director | Option Exercise | A | 0.78 | 10,000 | 7,800 | 10,000 | |
| Jun 21 2007 | CXIM | CRITICARE SYSTEMS ... | MOORE WILLIAM M | Director | Buy | P | 3.38 | 200 | 676 | 4,949 | 4.7 K to 4.9 K (+4.21 %) |
| Jun 21 2007 | CXIM | CRITICARE SYSTEMS ... | MOORE WILLIAM M | Director | Buy | P | 3.39 | 1,000 | 3,390 | 4,749 | 3.7 K to 4.7 K (+26.67 %) |
| Jun 21 2007 | CXIM | CRITICARE SYSTEMS ... | MOORE WILLIAM M | Director | Buy | P | 3.40 | 1,000 | 3,400 | 3,749 | 2.7 K to 3.7 K (+36.38 %) |
| Jun 21 2007 | CXIM | CRITICARE SYSTEMS ... | MOORE WILLIAM M | Director | Buy | P | 3.41 | 1,000 | 3,410 | 2,749 | 1.7 K to 2.7 K (+57.18 %) |
| Jun 21 2007 | CXIM | CRITICARE SYSTEMS ... | MOORE WILLIAM M | Director | Buy | P | 3.43 | 1,749 | 5,999 | 1,749 | 0 to 1.7 K |
Page: 1